As a Director of Strategic Partnership Alliances, Dr. Wanderer is responsible for effective collaboration of Synchrogenix Regulatory Writing Division of Certara with other Certara Divisions and Synchrogenix’s industry partners. With over 10 years of experience in the pharmaceutical industry, Dr. Wanderer brings innovative thinking and lean process-focused approach to support Synchrogenix’s vision of cutting-edge Regulatory Science, Strategy, and Services.
In her Director role, Dr. Wanderer builds on extensive regulatory writing consulting experience and her leadership of regulatory documentation efforts in support of US, EU, and Asian markets. Dr. Wanderer’s areas of expertise include rare diseases, oncology, cardiovascular diseases, CNS disorders, and respiratory disorders.
Dr. Wanderer’s dedication to innovation and science stems from a strong academic foundation. She received her PhD in Biochemistry from Cambridge University, United Kingdom as a Gates Scholar.